USPTO serial 88146199
Serial No. 88146199
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 9, 2020
- Examiner
- SINGH, TEJBIR
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with Serial No. 88146199?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $2,125
Owner
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
BioPhorum Operations Group Limited
Sheffield, GB
Other trademarks owned by BioPhorum Operations Group Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
Angela P. Doughty WARD AND SMITH, P.A.751 Corporate Center Drive, Suite 300Post Office Box 33009RALEIGH, NC 27607Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable electronic newsletters delivered by e-mail in the field of biopharmaceuticals and biotechnology | ACTIVE | — |
| 016 | Printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the biopharmaceutical field; printed matter, namely, books, reports, leaflets, pamphlets, flyers, articles, information sheets, manuals, newsletters, periodicals and journals all in the biotechnology field; research reports featuring biopharmaceutical and biotechnology data | ACTIVE | — |
| 035 | Business development services; business advisory services relating to product development; business project management for others in the fields of biopharmaceuticals and biotechnology; business management consultancy; corporate management consultancy; commercial management consultancy; business consultancy; business information; market research; business services, namely, formulation of best practices in the biopharmaceutical and biotechnology fields; expert evaluations and reports relating to business matters; conducting business and market research surveys; collection of market research information; analysis of market research data and statistics; computerized market research services; preparation of business reports; provision of marketing reports; market reports and studies; promoting collaboration within the science and research communities; promoting collaboration within the science and research communities to achieve advances in the field of biopharmaceuticals and biotechnology; promoting the exchange of information within the science and research communities; promoting the exchange of information within the science and research communities to achieve advances in the field of biopharmaceuticals and biotechnology; business research; business research consultation; arranging and conducting business conferences; providing an in-person business forum in the fields of biopharmaceuticals and biotechnology; business consultancy to the biotechnology and biopharmaceuticals industry; business introduction services; business project management services in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals | ACTIVE | — |
| 041 | Arranging and conducting seminars, workshops, educational conferences, and educational teleconferences, all in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals; arranging and conducting seminars, workshops, educational conferences, and educational teleconferences, all in the field of biotechnology and biopharmaceuticals; business training services; providing online training in the form of courses, seminars and workshops in the fields of biopharmaceuticals and biotechnology; providing an in-person educational forum in the fields of biopharmaceuticals and biotechnology; publishing services, namely, publishing of electronic publications in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; publishing of electronic publications in relation to regulatory matters, scientific matters, business information, product development, product supply chain, biopharmaceuticals and biotechnology industry and technology; education services, namely, arranging and conducting seminars, workshops, educational conferences, educational teleconferences, and online educational courses, in the field of healthcare, medical technology, medical devices, life sciences, pharmaceuticals, biotechnology or biopharmaceuticals; On-line electronic newsletters delivered by e-mail in the field of biopharmaceuticals and biotechnology | ACTIVE | — |
| 042 | Compiling data for research purpose in the field of medical science and medical consultancy; product development consultation; pharmaceutical research and development; consultancy on pharmaceutical product development, biopharmaceutical product development, biotechnology product development, medical device product development; technical research in the field of pharmaceutical studies; technical research in the field of biopharmaceuticals, biotechnology, medical devices and life science studies; technical consulting in the field of pharmaceutical studies; consultancy in the field of pharmaceutical research; testing, inspection, research, or development of pharmaceutical preparations; research on the subject of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; providing medical and scientific research information in the field of biopharmaceuticals, biotechnology, medical devices and life sciences; Developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Consultancy services in relation to developing quality control standards for pharmaceutical, biopharmaceutical and medical device manufacturing; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Consultancy services in relation to quality evaluation and analysis, quality assurance, and quality control, in the field of for pharmaceuticals, biopharmaceuticals, biotechnology, and medical devices; Advisory in the field of quality control of manufactured goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks owned by BioPhorum Operations Group Limited
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2026 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Sep 4, 2026 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Sep 3, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jun 8, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jun 9, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jun 9, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 24, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 24, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 19, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 19, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 18, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 18, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 18, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 14, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 9, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 19, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 21, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 21, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 18, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 17, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 12, 2018 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Oct 12, 2018 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Oct 11, 2018 | NWAP | NEW APPLICATION ENTERED | — |